Athena Countouriotis's Net Worth
Athena Countouriotis's net worth is estimated to be at least $5,959,020.14 as of 05/03/2024. CoreStreet's estimation of Athena Countouriotis's net worth is based on their sale of stock and current holding of stock.
Athena Countouriotis is CEO at Turning Point Therapeutics Inc. They have executed at least 7 trades of stock as per SEC Form 4 filings. Their most recent trade was for 2,971 units of TPTX stock on 02/09/2022. Their biggest sale was on 02/09/2021 when they sold 25,666 units of Turning Point Therapeutics Inc stock for $3,559,360.88. They typically trade 1 times per year.
Total value of insider buys:
- $1,063,360.00
Total value of insider sells:
- $4,895,660.14
Most recent insider trade:
- Feb. 9, 2022
Athena Countouriotis's Insider Trading History
| Turning Point Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 9, 2022 | CEO | 2,971 | $36.30 | Sell | $107,847.30 |
Feb. 11, 2021 | CEO | 8,942 | $137.38 | Sell | $1,228,451.96 |
Feb. 9, 2021 | CEO | 25,666 | $138.68 | Sell | $3,559,360.88 |
May 21, 2020 | CEO | 4,166 | $60.00 | Buy | $249,960.00 |
Sept. 10, 2019 | CEO | 10,000 | $45.00 | Buy | $450,000.00 |
April 22, 2019 | CEO | 12,000 | $18.00 | Buy | $216,000.00 |
| Passage Bio Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 24, 2020 | Director | 10,000 | $14.74 | Buy | $147,400.00 |